April 15, 2012

Breast Cancer Study Finds New Type of Mutation


Mayo Clinic researchers have discovered a new class of molecular mutation in various forms of breast cancer, a finding that may shed new light on development and growth of different types of breast tumors. Called fusion transcripts, the mutated forms of RNA may also provide a way to identify tumor subtypes and offer new strategies to treat them, investigators say…"But breast cancer is much more complex than indicated by these three subtypes, and one of the challenges of treating the disease is to identify gene markers that predict how a tumor will respond to a specific treatment," says senior investigator Edith Perez, M.D., deputy director of the Mayo Clinic Comprehensive Cancer Center in Florida and director of the Breast Cancer Translational Genomics Program, which involves researchers at all three Mayo Clinic campuses.

Additional coverage: Post-Bulletin



Bioscience Technology   4/15/12

Tags: Breast Cancer, Dr. Edith Perez, Genomics, Mayo Clinic's Breast Cancer Translational Genomics Program, molecular mutation, Research

Please sign in or register to post a reply.
Contact Us · Privacy Policy